Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging-Reference-Cited by-同舟云学术

Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging

Published:2021-09-30 Issue:1 Volume:63 Page:59-68
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Jadvar Hossein,Calais Jeremie,Fanti Stefano,Feng Felix,Greene Kirsten L.,Gulley James L.,Hofman Michael,Koontz Bridget F.,Lin Daniel W.,Morris Michael J.,Rowe Steve P.,Royce Trevor J.,Salami Simpa,Savir-Baruch Bital,Srinivas Sandy,Hope Thomas A.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference91 articles.

1. Cancer Statistics, 2021

2. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

3. NCCN guidelines insights: prostate cancer, version 1.2021;Schaeffer;J Natl Compr Canc Netw.,2021

4. Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations

5. PET/CT with 11C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations from the Galician Oncological Society and the Galician Society of Nuclear Medicine for the use of 177Lu-PSMA-617 radioligand-therapy in prostate cancer;Clinical and Translational Oncology;2024-09-12

2. The added value of 68Ga-PSMA PET/CT in anatomical staging of prostatic carcinoma in correlation with the histopathological zonal staging;Egyptian Journal of Radiology and Nuclear Medicine;2024-09-09

3. Rate of unspecific bone uptake on PSMA PET is determined by the Scaffold – not the Radionuclide. Letter regarding: “The homunculus of unspecific bone uptakes associated with PSMA- targeted tracers: a systematic review-based definition” and “Cutting back on overdiagnosis – Occam’s razor and unspecific bone uptakes in PSMA PET“;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-03

4. PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis;Recent Patents on Anti-Cancer Drug Discovery;2024-08

5. Interlesional response heterogeneity is associated with the prognosis of abiraterone treatment in metastatic castration-resistant prostate cancer;Med;2024-08